A Clinical Study to Evaluate the Safety and Efficacy of Hemp Seed Oil in Epilepsy Management

Not Applicable

• Conditions: Health Condition 1: G409- Epilepsy, unspecified

• Registration Number: CTRI/2023/01/048959
• Lead Sponsor: amrata Hempco Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Male and female subjects with epilepsy history, ranging in age from 18 to 45 years.

2.Willingness to follow the protocol requirements as evidenced by written, informed consent.

3.Mentally, physically and legally eligible to give informed consent

4.Willingness to complete study questionnaires

Exclusion Criteria

1.Patients with pre-existing other severe systemic disease necessitating long-term medication.

2.Significant medical or psychiatric illness

3.History of cancer, including solid tumors, hematologic malignancies and carcinoma in situ

4.Any vascular or systemic disorder which could affect any of the efficacy assessments

5.Participation in the current or previous treatment with any approved or investigational health supplement(s) during the past 1 month

6.Subjects received other medication (anti-viral) within the 36 hours before entry into the study

7.Patients who had immunization against influenza or influenza like illnesses for that season.

8.Inability to comply with the study protocol, including psychiatric diseases

9.Immune compromised or with other clinically active illness including cardiac or pulmonary diseases, hemoglobinopathies, renal dysfunction

10.Having vaccination of a seasonal or new influenza A (H1N1) vaccine 6 months before

11.Other reasons that researchers think not fitting to participate in the study

12.Evidence of significant uncontrolled comorbid disease which in the investigator opinion would jeopardize patient participation

13.Patient tested positive with Covid 19

Study & Design

• Study Type: Interventional
• Study Design: Not specified